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repeated for AAAs that are larger than 5.5 cm. Data on
nonintervention for AAAs that are larger than 5.5 cm,
therefore, will have to be gleaned from indirect sources.
Endoluminal repair5,6 and laparoscopically assisted
approaches7 are applicable to patients at high risk of com-
plications after conventional surgery.8,9 However, this is
based on the assumption that these patients die from a rup-
tured AAA. To date, there are few data to support or refute
an aggressive approach in patients with AAAs that are
larger than 5.5 cm who are unfit to undergo open repair.
In our practice, we prospectively maintain a record of
all patients turned down for elective repair of an AAA that
is larger than 5.5 cm. Before establishing an endoluminal
service, we reviewed records to determine the prognosis of
this subset of patients with large aneurysms. We wished to
determine whether an aggressive approach to treatment in
patients with a large AAA who are unfit for open repair
could be justified.
PATIENTS AND METHODS
A log was prospectively maintained in our unit from
1989 to 1999 of all patients turned down for elective
In 1998, the United Kingdom (UK) small aneurysm
trial collaborators demonstrated no clear advantage for
surgery over surveillance for abdominal aortic aneurysms
(AAAs) that were smaller than 5.5 cm in diameter.1
Autopsy studies based on clinical and radiographic assess-
ment of aneurysm size suggest a correlation between size
and rupture risk.2-4 However, these reports predated cur-
rent imaging technologies and did not allow risk stratifica-
tion according to size at presentation. Nonetheless, these
historical data, with questions of equipoise, dictate that it
is highly unlikely that the UK aneurysm trial will be
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Purpose: The United Kingdom Small Aneurysm study has demonstrated the low risk of rupture in aneurysms less than
5.5 cm in diameter. With the advent of endoluminal techniques, patients considered unfit to undergo laparotomy are
now considered for endovascular repair. However, the natural history of aneurysms larger than 5.5 cm remains uncer-
tain, especially when severe comorbidity is present. In our center, we prospectively maintain records of all patients for
whom elective aneurysm surgery was refused. This study documented the outcome of all patients referred with abdom-
inal aortic aneurysms (AAAs) larger than 5.5 cm in diameter who were turned down for elective open repair and deter-
mined the cause of death and risk of rupture in all patients.
Methods: Details of all patients with AAAs from January 5, 1989, to January 5, 1999, were recorded, and demographic
details on all patients with AAAs larger than 5.5 cm were collected. Copies of death certificates were obtained from the
Office of National Statistics, local in-hospital patient records, and general practitioner records. Results of postmortem
examinations were also obtained. Aneurysms were stratified according to their size at presentation (5.5-5.9 cm, 6.0-
7.0 cm, and > 7.0 cm), and the reasons no intervention was made were documented.
Results: A total of 106 patients were turned down for elective aneurysm surgery in the 10-year period (10.6 per year). The
mean age of the patients was 78.4 years (SD, 7.4), and 70 were men and 36 were women. At the end of the study, 76
patients (71.7%) had died. Overall, the 3-year survival rate was 17%. Patients with AAAs larger than 7.0 cm lived a median
of 9 months. A ruptured aneurysm was certified as a cause of death in 36% of the patients with an AAA of 5.5 to 5.9 cm,
in 50% of the patients with an AAA of 6 to 7.0 cm, and 55% of the patients with an AAA larger than 7.0 cm. Reasons given
for not intervening were patient refusal (31 cases), the patient being “unfit for surgery” (18 cases), the “advanced age” of
the patient (18 cases), cardiac disease (9 cases), cancer (9 cases), respiratory disease (6 cases), and other (15 cases).
Conclusion: Although we recognize the problems with death certification, we found that rupture was a significant cause
of death in patients with an untreated AAA that was larger than 5.5 cm. Although little difference in outcome was
observed in aneurysms in the 5.5 to 7.0 cm size range, patients with an AAA that was larger than 7.0 cm seemed to
have a much poorer prognosis. (J Vasc Surg 2001;33:752-7.)
repair of an AAA. Reasons for not intervening in patients
with an AAA were obtained from a prospectively main-
tained database between 1989 and 1999. Hospital records
on all patients were retrieved to confirm demographic
details and reasons for not intervening. The records of
local general practitioners and the area health authority
were also checked to ascertain the date of death of 18
patients. Inpatient hospital files confirmed the date of
death of 55 patients. Thirty-three outstanding patients
were tracked with the help of the Office of National
Statistics. Copies of the death certificates were obtained
for all deceased patients. Whenever applicable, all autopsy
reports were obtained. The date of death and the cause of
death as it appeared on the death certificate or the certi-
fied cause of death were documented.
Patients who had an infrarenal AAA that was larger than
5.5 cm maximum diameter on ultrasound scanning at the
time of the first examination and who were referred specif-
ically for an opinion about operative repair of their AAA
were included in the study. The need for surgery later did
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not exclude patients from this study. Patients with primary
thoracic aneurysms, false aneurysms, or suprarenal expan-
sion after earlier aortic surgery and patients with an urgent
presentation of an AAA were excluded. None of the
patients in this series were considered for endoluminal AAA
repair, because this study predated the establishment of our
endovascular program.
Between 1989 and 1999, 106 patients were eligible
for inclusion in the study. Patients were divided into three
groups solely according to AAA size at initial examination.
The size groups were: 5.5 to 5.9 cm, 6.0 to 7.0 cm, and
larger than 7.0 cm. Serial measurements were not taken.
Criteria for “unfit” patients. Most patients were
turned down for intervention by an experienced vascular
surgeon on clinical grounds alone. The clinical decision
was made on the basis of concurrent illnesses and general
cardiovascular or respiratory fitness. In those cases in which
there was doubt, patients were admitted to the hospital for
cardiac and respiratory investigations, and their cases were
reviewed by a consultant vascular anesthetist.
Statistical method. Kaplan-Meier life tables were
constructed from the observed data. End points were time
Fig 1. Survival free of ruptures, all sizes of aneurysms.
Fig 2. Survival free of rupture, aneurysms 5.5 to 5.9 cm in diameter.
Fig 3. Hazard of rupture, aneurysms 5.5 to 5.9 cm in diameter.
Fig 4. Survival free of rupture, aneurysms 6.0 to 7.0 cm in diameter.
of death or close of the study. Cumulative survival plots
comparing the survival rate of patients who died of an
aneurysm rupture with the survival rate of patients who
died from other causes were constructed. Patients alive at
the close of the study were “censored” to the nonrupture
group. Patients were stratified into three groups according
to the size of the AAA at initial examination (5.5-5.9 cm,
6.0-7.0 cm, and > 7.0 cm), and cumulative survival curves
were calculated for each group. From the life tables,
cumulative hazards were also calculated and plotted for
each of the three groups.
RESULTS
Demographics and aneurysm size. One hundred six
patients were identified. All patients had been referred for
the assessment of their suitability for elective AAA repair.
The mean age of the patients was 78.4 years (SD, 7.4), and
70 patients were men and 36 were women (ratio, 1.9:1).
All aneurysms were larger than 5.5 cm on maximum
anteroposterior or transverse diameter at the time of the ini-
tial examination. Twenty-three patients (22%) with a mean
age of 78.6 years at the time of the initial examination (14
men, 9 women) had an aneurysm 5.5 to 5.9 cm in diame-
ter; 62 patients (58%) with a mean age of 78.0 years (39
men, 23 women) had an aneurysm 6.0 to 7.0 cm in diam-
eter; and 21 patients (20%) with a mean age of 79.0 years
(17 men, 4 women) had an aneurysm larger than 7.0 cm.
Reasons for not intervening. Thirty-one patients
(29%) refused operative intervention when the procedure
and risks were explained to them. Eighteen patients (17%)
were generally classified as “unfit for surgery.” Eighteen
patients (17%) were older than 80 years, and this was
somewhat misleadingly given as the reason for not inter-
vening. Age itself was not the chief determining factor;
these patients also had significant cardiac and respiratory
disease. Cardiac disease precluded nine patients (9%) from
intervention, and respiratory disease precluded six more
patients (6%). Malignancy accounted for the reason for
not intervening in nine patients (9%), and dementia and
neurologic disease were the reasons for precluding four
more patients (3%). Miscellaneous other causes accounted
for the reasons for precluding the remaining 11 patients
(10%) from intervention (Table I).
Patient survival and causes of death. Follow-up was
complete on all patients. By the end of the study, 76
patients had died, and 30 patients remained alive. Of the
patients who died, 39 were certified as having died of non-
rupture, causes, and 37 were certified as dying of a ruptured
AAA. Of the 12 patients on whom a postmortem examina-
tion was performed, 11 were found to have died of a rup-
tured AAA, and one was found to have died of a myocardial
infarction. Two other patients whose death certificates
stated “multisystem organ failure” died after surgery for a
ruptured AAA. By means of life-table analysis, the 1-, 2-,
and 3-year survival rates for our 106 patients were 54%,
40%, and 17%, respectively (Fig 1).
In the 76 patients who died by the end of the study,
the median survival time was 9 months (range, 1-91
months). The median time to certified rupture was 9
months (range, 1-78 months). The median survival time
of those certified as dying of nonrupture causes was 10
months (range, 1-91 months).
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Fig 5. Hazard of rupture, aneurysms 6.0 to 7.0 cm in diameter.
Fig 6. Survival free of rupture, aneurysms larger than 7.0 cm in
diameter.
Fig 7. Hazard of rupture, aneurysms larger than 7.0 cm in diameter.
The certified causes of death in patients whose deaths
were not attributed to a rupture were cancer (11 patients),
acute myocardial infarction/congestive cardiac failure (11
patients), pneumonia (5 patients), stroke (2 patients),
multisystem organ failure after emergency AAA repair (2
patients), chronic renal failure (3 patients), “old age” (2
patients), and other (3 patients).
Survival free of rupture. An indication of the contri-
bution of rupture to overall patient survival was gleaned by
means of a more sophisticated analysis of the data. In the
group of patients with an AAA measuring 5.5 to 5.9 cm on
ultrasound scanning, there was little difference between
the survival free of rupture curves for patients who died of
“rupture” and those of patients who died of “nonrupture”
causes. However, for the group of patients with an AAA
measuring 6.0 to 7.0 cm, the risk or hazard of dying of a
ruptured AAA, as opposed to a nonrupture cause, became
apparent as early as 6 months. The increased risk of rupture
also became apparent in the group of patients with an AAA
larger than 7.0 cm at 6 months (Figs 3-7).
Patient survival related to the size of AAA at initial
examination. Of the 23 patients with an AAA measuring
5.5 to 5.9 cm at the time of the initial examination, 14
were dead by the end of the study, with a median survival
time of 10 months (range, 1-78 months). The deaths of
five of these 14 patients were certified as caused by a rup-
tured aneurysm. Of the 62 patients with an AAA measured
at 6.0 to 7.0 cm, 42 died, with a median survival time of
11.5 months (range, 1-91 months). The deaths of 21 of
these 42 patients were caused by rupture. Twenty of the 21
patients with an AAA larger than 7.0 cm died; 11 of the 20
deaths were caused by rupture. The median survival of
these 20 patients was just 9 months (range, 1-72 months).
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Patients undergoing emergency surgery. Four patients
who were initially turned down for elective repair  ruptured
during the study period. Two of these patients died during
the perioperative period, and the other two patients were still
alive at 33 months and 41 months after surgery. Two of these
patients had initially refused surgery, and the other two
patients fell into the category of “unfit for surgery.”
Survival data on 31 patients who refused surgery.
Of the 31 patients whose documented reason for no inter-
vention was “refused surgery” (17 men, 14 women; mean
age, 78.6 years), 11 were alive at time of follow-up (1 at
41 months after emergency repair) and 20 were dead. The
causes of death of the 20 patients who died were certified
as ruptured AAA (10 patients), death after emergency
repair (2 patients), and other nonrupture causes (8
patients). The 1- and 2-year survival rates of these patients
were 68% and 45%, respectively.
DISCUSSION
Endovascular repair for AAAs may widen the indica-
tions for repair, given its less-invasive nature. Proponents
of the technique suggest that early results justify its use in
the treatment of older patients who are at higher risk.10
Although there is little doubt that technical successes are
possible for patients who are unfit for open surgery, one
must question whether this represents an appropriate use
of health care resources or whether it can improve their
long-term survival.
Table II. Comparison of Szilagyi’s 1972 figures and the
results from Cardiff
Cardiff 2000 Detroit 1972
No. died 76 90
2-year survival rate 39% 40%
Aneurysm < 6 cm 18.4% 69%
Aneurysm > 6 cm 81.6% 31%
Percent ruptured 49% 28%
Table I. Reasons given for not intervening
Reason given No.
Patient refusal 31
“Unfit for surgery” (multifactorial) 18
“Advanced age” (> 80 y) 18
Cardiac disease 9
Cancer 9
Respiratory disease 6
Dementia, paraplegia 4
Other 11
Total 106
Table III. Certified nonrupture causes of death
Cause of death n
Cancer 11
Myocardial infarction/congestive cardiac failure 11
Pneumonia 5
Stroke 2
Multisystem organ failure 2
Chronic renal failure 3
“Old age” 2
Other 3
Table IV. Survival rates
Survival
time (mo) SE 95% CI
Overall
Mean 23.07 2.13 18.89, 27.24
Median 17.00 3.22 10.69, 23.31
5.5-5.9 cm
Mean 25.22 4.78 15.85, 34.58
Median 19.00 7.99 3.35, 34.65
6.0-7.0 cm
Mean 25.13 2.88 19.49, 30.77
Median 19.00 2.95 13.21, 24.79
> 7.0 cm
Mean 15.62 4.37 7.04, 24.19
Median 9.00 1.51 6.04, 11.96
In 1970, Szilagyi11 recognized the need to examine
the outcome of patients who were turned down for elective
open repair of an AAA, to “. . . cast light on the liberal
operative indications we have observed. . . .” He examined
his experience with 156 patients who were turned down
for elective repair in 19 years. This represented 24% of all
patients referred to his unit. The mean size of AAAs in
these patients was estimated to be “small” (< 6 cm) in 69%
of cases and “large” (> 6 cm) in 31% of cases. Ultimately,
90 patients who did not undergo surgery had died by the
end of the study. The main reason given for not interven-
ing in the Szilagyi study was systemic atherosclerosis,
mainly coronary artery disease. Not surprisingly, therefore,
41% of their patient group died of coronary artery disease
and 12% of the patient group died of strokes. However, the
second most common cause of death was a ruptured AAA,
which occurred in 28% of the patients who did not
undergo surgery. In these patients, 40% had an AAA that
ruptured within 1 year of presentation. The 2-year survival
rate of patients turned down for elective repair was 40%,
with a mean survival time of 25.9 months.
In our study, 106 patients were initially turned down
for surgery, and 76 of these patients had died by the end of
the study. All AAAs were found to be larger than 5.5 cm
maximum in diameter with ultrasound scanning. In con-
trast to Szilagyi’s study, 81.6% of patients included in our
study had “large” aneurysms as measured by means of ultra-
sound, and 18.4% of patients had “small” aneurysms (Table
II). Because death certificates were obtained for all patients
in our study, data on survival are undoubtedly accurate.
However, we also relied on death certificate data for causes
of death and, therefore, must acknowledge potential pitfalls
in attributing the cause of death. Although only 12 autop-
sies were performed in this study, all except one revealed a
ruptured AAA as a cause of death, which may suggest that
rupture is a relatively frequent cause of death in this patient
group. The median survival period of all patients in this
study was 17 months. However, patients with an AAA
larger than 7.0 cm at the initial examination had a worse
prognosis, with a median survival period of only 9 months.
Of these patients, half were certified as having died of a rup-
tured AAA. The cause of the relatively poor survival in this
group may be the more aggressive approach that was
applied to very large AAAs in our unit.
In patients with an AAA in the 5.5 to 5.9 cm range,
no substantial differences in survival were shown between
patients dying of a ruptured AAA and those dying of other
causes by means of hazard analysis at any time point. This
would suggest that an aggressive approach to AAA repair
in these patients was unlikely to improve the long-term
survival rate. An increased risk of death caused by rupture
only became apparent in patients with an AAA larger than
6.0 cm, supporting the observations of Scott et al in
Chicester,12 who advocate an aggressive approach only in
patients with an AAA larger than 6.0 cm. However,
although an aggressive approach in patients with AAAs in
the 6.0 to 7.0 cm and larger than 7.0 cm group may have
yielded an improved overall survival, half the patients in
the larger than 7.0 cm group who died of “nonrupture”
causes were dead at 16 months.
Criteria for not intervening are difficult to define. The
main reason given for patients not undergoing surgery in
this study was “patient refusal.” However, by reviewing
case notes on these patients, we found that these patients
had multiple comorbidities and would have been at a very
high risk for any surgical intervention. “Patient refusal,”
therefore, in these cases probably would have been more
correctly termed “surgeon and anesthetist refusal.”
Therefore, it is important to know the survival data for
this subset of patients. One- and 2-year survivals for these
patients are not significantly different from those of the
rest of the patients studied. Certified rupture occurred in
approximately half of these patients. Somewhat more con-
troversial in the current climate is the listing of “advanced
age” as a reason for not intervening. Again, although this
was the primary stated reason in outpatient letters, it was
clear from the case notes that advanced age was only one
of many risk factors.
Although we were reasonably satisfied that our assess-
ment identified patients unfit for intervention, the discov-
ery that two of our patients who were turned down for
surgery eventually survived emergency repair led us to
reexamine our data. Had we been too liberal in writing off
some patients? Perhaps, among the 31 patients who
“refused surgery,” we could identify three to four patients
who may have survived open operations. However, given
the cumulative survival free of risk curves, we were satis-
fied that these patients were treated appropriately.
Recently, Jones et al13 reported their experience of 50
patients turned down for elective AAA repair who died
during the follow-up period. The mean age of their
patients was 81 years, which was similar to the mean age
of our study group. The reasons for not intervening in
their study were similar to those in ours, and their autopsy
rate of 14% was almost identical to ours. Overall, 19 of 50
deaths (38%) were attributed to a ruptured AAA. This
compares with 49% in our series. However, 48% of their
patients had an AAA smaller than 6 cm at the time of entry
into their study, compared with 18.4% in our study. This
may account for the slightly larger number of deaths cer-
tified as caused by rupture in our study.
An inherent problem with papers on the natural his-
tory of AAAs is that rupture risk is described according to
maximum diameter at initial presentation. This is mis-
leading. Reed et al14 prospectively followed up aneurysms
with routine sonographic surveillance in 181 patients.
They found a median growth rate for AAAs of 0.21 cm/y.
However, they concluded that when AAAs are pros-
pectively measured, aneurysm growth rate is not accu-
rately predicted by means of size at initial presentation
nor by initial aneurysm growth rate. This may account 
for the somewhat higher than expected rupture rates 
for patients with an AAA measuring less than 7.0 cm at
initial presentation.
An obvious question is whether, in retrospect, any of
these patients could have been treated endovascularly
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and had a better long-term outcome. Of the 106
patients, 13 had either cancer or dementia and would
not have been considered for endovascular treatment.
Of the remaining 93 patients, we speculated that 30
might have aneurysms suitable for repair (based on our
initial endovascular experience). Of these patients,
approximately half (15 patients) might have died of a
rupture (based on this study). Accepting an optimistic
operative mortality rate of 10% (3 of 30 patients), we
conclude that 12 patients (11%) might have benefitted
from current treatments.
In the 30 years since Szilagyi’s study, little seems to
have changed. One might reasonably infer that these
data are a needless reiteration of well-known truths and
that patients turned down for elective open repair of an
AAA have a poor prognosis. However, the relevance of
this study comes from AAA diameter at presentation
being measured sonographically. This allowed for a
prognosis based on AAA size at presentation and
ensured that, in keeping with the recommendations of
the UK Small Aneurysm Trial, patients with AAAs
smaller than 5.5 cm on ultrasound scans were excluded.
Therapeutic options are also now more diverse and
potentially less invasive than they were in Szilagyi’s time.
Proposed trials of endovascular repair are set to focus on
this precise group of patients in the absence of contem-
porary survival data. The real value of this study, there-
fore, is in confirming that patients turned down for
elective AAA repair have an inherently poor prognosis
and that intervention ought to be carefully considered.
In the light of this study, we question the tenet that
endovascular repair allows patients unfit for open repair
to be treated. Finally, this study provides us with data
based on modern imaging technology with which to
debate the health economics of minimally invasive ther-
apeutics in an inherently ill group of patients.
REFERENCES
1. The UK Small Aneurysm Trial Participants. Mortality results for ran-
domised control trial of early elective surgery or ultrasonographic surveil-
lance for small abdominal aortic aneurysms. Lancet 1998;352:1649-55.
2. Darling RC. Ruptured arteriosclerotic abdominal aortic aneurysms—
a pathologic and clinical study. Am J Surg 1970;119:397-401.
3. Szilagyi DE, Smith RF, DeRusso FJ, Elliott JP, Sherrin FW.
Contribution of abdominal aortic aneurysmectomy to prolongation of
life. Ann Surg 1966;164:678-99.
4. Darling RC, Messina CR, Brewster DC, Ottinger LW. Autopsy study
of unoperated abdominal aortic aneurysms. The case for early resec-
tion. Circulation 1977;56(3 Suppl):II161-4.
5. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft
implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:
491-9.
6. Blum U, Voshage G, Lammer J, Beyersdorf F, Tollner D, Kretschmer
G, et al. Endoluminal stent-grafts for infrarenal abdominal aortic
aneurysms. N Eng J Med 1997;336:13-20.
7. Cerveira JJ, Cohen JR. Laparoscopically assisted abdominal aortic
aneurysm repair. Surg Clin North Am 1999;79:541-50.
8. Criado FJ, Fry PD, Machan LS, Twena M, Patten P. The Talent endo-
luminal AAA stent-graft system.: report of the phase I USA trial, and
summary of world-wide experience. J Mal Vasc 1998;23:371-3.
9. Uflscker R, Robison JG, Brothers TE, Pereira AH, Sanvitto PC.
Abdominal aortic aneurysm treatment: preliminary results with the
Talent graft-stent system. J Vasc Interv Radiol 1998;9:51-60.
10. Harris PL. The highs and lows of endovascular aneurysm repair: the
first two years of the Eurostar Registry. Ann R Coll Surg Engl 1999;81:
161-5.
11. Szilagyi DE, Elliot JP, Smith RF. Clinical fate of the patient with
asymptomatic abdominal aortic aneurysm and unfit for surgical treat-
ment. Arch Surg 1972;104:600-6.
12. Scott RA, Ashton HA, Lamparelli MJ, Harris GJ, Stevens JW. A 14-
year experience with 6 cm as a criterion for surgical treatment of
abdominal aortic aneurysm. Br J Surg 1999;86:1317-21.
13. Jones A, Cahill D, Gardham R. Outcome in-patients with large
abdominal aortic aneurysms considered unfit for surgery. Br J Surg
1998;85:1382-4.
14. Reed WW, Hallet JW Jr, Damiano MA, Ballard DJ. Learning from the
last ultrasound. A population-based study of patients with abdominal
aortic aneurysm. Arch Int Med 1997;157:2064-8.
Submitted Jun 20, 2000; accepted Sep 13, 2000.
